解读PEGylated氧化铁纳米颗粒的肝细胞相互作用
Jianxian Ge1,2, Jieya Chen1, Ning Wang1
1State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, Jiangsu 215123, China.
纳米粒子大小和PEGylation影响肝脏积累. 较小的颗粒通过脏被清除,而较大的颗粒积聚在肝脏中,2K PEG提供最佳的循环和减少肝脏吸收.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 肝病学 肝病学是一种肝病学.
背景情况:
- 纳米颗粒的肝脏积累减少了它们在生物医学应用中的有效性.
- 了解纳米粒子物理化学特性如何影响肝脏相互作用至关重要.
研究的目的:
- 为了研究大小和PEG链长度对氧化铁纳米粒子肝脏相互作用的影响.
- 为了阐明纳米颗粒在肝脏吸收的细胞机制.
主要方法:
- 使用99mTc标记的铁氧化物纳米颗粒,尺寸不同 (3.6,12.0nm) 和PEG链长 (1K,2K,5K).
- 在体内进行SPECT/CT成像用于生物分布分析.
- 使用原始肝细胞进行的体外研究:肝细胞 (HCs),肝脏侧侧内皮细胞 (LSECs),库弗弗细胞 (KCs) 和肝脏星状细胞 (HSCs).
主要成果:
- 较小的纳米颗粒最初被脏清除,而较大的纳米颗粒显示出明显的肝脏和脏积累.
- 较长的PEG链通常会增加循环时间和减少肝脏吸收; 2K PEG导致肝脏积累最低.
- 试验室研究揭示了一种新的吸收趋势:HCs ∼HSCs > LSECs > KCs,挑战了库普费尔细胞在纳米粒子清除中的优势.
- 在体内发现与小颗粒的肝脏积累与HC吸收以及大颗粒的积累与LSEC和KC相互作用相关.
结论:
- 纳米粒子大小和PEGylation是肝脏相互作用和生物分布的关键决定因素.
- 细胞微环境显著影响纳米肝相互作用,肝细胞在小纳米粒子吸收中发挥关键作用.
- 这些发现为优化纳米药物的设计提供了指导,以增强特异性并最大限度地减少非目标肝脏积累.
更多相关视频
08:13Using Magnetometry to Monitor Cellular Incorporation and Subsequent Biodegradation of Chemically Synthetized Iron Oxide Nanoparticles
Published on: February 27, 2021
08:13Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
Published on: March 22, 2016
相关概念视频
Oxidation Numbers
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Oxidation-Reduction Reactions
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
